UBS Group’s Nutrien NTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $81.4M | Buy |
1,078,557
+14,541
| +1% | +$1.04M | 0.01% | 1209 |
|
|
2025
Q4 | $65.7M | Sell |
1,064,016
-106,290
| -9% | -$6.26M | 0.01% | 1360 |
|
|
2025
Q3 | $68.7M | Sell |
1,170,306
-335,392
| -22% | -$19.5M | 0.01% | 1331 |
|
|
2025
Q2 | $87.7M | Buy |
1,505,698
+83,269
| +6% | +$4.71M | 0.02% | 1060 |
|
|
2025
Q1 | $70.7M | Buy |
1,422,429
+194,211
| +16% | +$9.94M | 0.01% | 1170 |
|
|
2024
Q4 | $55M | Buy |
1,228,218
+69,118
| +6% | +$3.28M | 0.01% | 1378 |
|
|
2024
Q3 | $55.7M | Buy |
1,159,100
+5,874
| +0.5% | +$283K | 0.01% | 1080 |
|
|
2024
Q2 | $58.7M | Buy |
1,153,226
+89,489
| +8% | +$4.9M | 0.01% | 926 |
|
|
2024
Q1 | $57.8M | Buy |
1,063,737
+52,599
| +5% | +$2.74M | 0.01% | 952 |
|
|
2023
Q4 | $57M | Sell |
1,011,138
-43,747
| -4% | -$2.47M | 0.02% | 909 |
|
|
2023
Q3 | $65.1M | Buy |
1,054,885
+36,393
| +4% | +$2.3M | 0.02% | 699 |
|
|
2023
Q2 | $60.1M | Buy |
1,018,492
+38,557
| +4% | +$2.45M | 0.02% | 725 |
|
|
2023
Q1 | $72.4M | Buy |
979,935
+41,197
| +4% | +$3.18M | 0.03% | 597 |
|
|
2022
Q4 | $68.6M | Sell |
938,738
-99,617
| -10% | -$7.87M | 0.03% | 645 |
|
|
2022
Q3 | $86.6M | Sell |
1,038,355
-130,110
| -11% | -$11.2M | 0.04% | 476 |
|
|
2022
Q2 | $93.1M | Sell |
1,168,465
-66,484
| -5% | -$6.46M | 0.04% | 474 |
|
|
2022
Q1 | $128M | Buy |
1,234,949
+171,393
| +16% | +$14.2M | 0.04% | 435 |
|
|
2021
Q4 | $80M | Buy |
1,063,556
+49,280
| +5% | +$3.45M | 0.02% | 701 |
|
|
2021
Q3 | $65.8M | Sell |
1,014,276
-28,975
| -3% | -$1.77M | 0.02% | 721 |
|
|
2021
Q2 | $63.2M | Buy |
1,043,251
+95,502
| +10% | +$5.65M | 0.02% | 720 |
|
|
2021
Q1 | $51.1M | Sell |
947,749
-81,093
| -8% | -$4.41M | 0.02% | 831 |
|
|
2020
Q4 | $49.5M | Buy |
1,028,842
+59,374
| +6% | +$2.62M | 0.02% | 794 |
|
|
2020
Q3 | $38M | Buy |
969,468
+92,992
| +11% | +$3.39M | 0.01% | 790 |
|
|
2020
Q2 | $28.1M | Sell |
876,476
-69,992
| -7% | -$2.44M | 0.01% | 886 |
|
|
2020
Q1 | $32.1M | Sell |
946,468
-300,787
| -24% | -$12M | 0.02% | 746 |
|
|
2019
Q4 | $59.8M | Sell |
1,247,255
-14,353
| -1% | -$694K | 0.02% | 667 |
|
|
2019
Q3 | $82.6M | Sell |
1,261,608
-31,109
| -2% | -$1.59M | 0.03% | 464 |
|
|
2019
Q2 | $69.1M | Buy |
1,292,717
+18,596
| +1% | +$971K | 0.03% | 525 |
|
|
2019
Q1 | $67.2M | Buy |
1,274,121
+48,619
| +4% | +$2.53M | 0.03% | 504 |
|
|
2018
Q4 | $57.6M | Sell |
1,225,502
-63,022
| -5% | -$3.29M | 0.03% | 536 |
|
|
2018
Q3 | $74.3M | Sell |
1,288,524
-91,553
| -7% | -$5.07M | 0.03% | 508 |
|
|
2018
Q2 | $75M | Buy |
1,380,077
+188,409
| +16% | +$9.35M | 0.03% | 496 |
|
|
2018
Q1 | $56.3M | Buy |
+1,191,668
| New | +$59.7M | 0.02% | 585 |
|
Other funds holding NTR
VCM
UBS Group's NTR Position: Q1 2026 in Review
UBS Group increased its Nutrien (NTR) stake by 1.4% in Q1 2026, buying an estimated $1.04M and bringing the position to 1,078,557 shares worth $81.4M. The position accounts for 0.01% of the portfolio, ranked #1209.
UBS Group first reported a position in NTR in Q1 2018 and has held it in 33 quarters since. The position peaked at $128M in Q1 2022. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.
- UBS Group held 1,078,557 shares of Nutrien worth $81.4M as of Q1 2026.
- UBS Group bought 14,541 Nutrien shares in Q1 2026, an estimated $1.04M.
- Nutrien made up 0.01% of UBS Group's portfolio in Q1 2026, its #1209 holding.
- UBS Group first reported a position in Nutrien in Q1 2018 and has held it in 33 quarters since.
- UBS Group's Nutrien position peaked at $128M in Q1 2022.
- 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.